Valorum Biologics
Blood & Organ Banks · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
555 Madison Ave Ste 1201, New York, New ...Website
valorum.bioRevenue
<$5 MillionIndustry
About Valorum Biologics
Valorum Biologics Org Chart
Is Valorum Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Valorum Biologics has new funding data
Check out if Valorum Biologics is spiking on competitors!
Click to see if Valorum Biologics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Valorum Biologics recently announced quarterly report
Valorum Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Valorum Biologics launches new products
Check if Valorum Biologics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Valorum Biologics
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Valorum Biologics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Valorum Biologics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Valorum Biologics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Valorum Biologics.
Valorum Biologics Tech Stack
A closer look at the technologies used by Valorum Biologics
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Valorum Biologics
Valorum Biologics is dedicated to enhancing patient access to biologic drugs by providing affordable and effective biosimilars, particularly in the fields of ophthalmology and oncology. The company focuses on developing and commercializing high-quality assets in underserved markets, positioning itself as a disruptor in the pharmaceutical industry.... Read More